Results 111 to 120 of about 467,321 (167)

Soluble guanylate cyclase modulators-a novel therapeutic approach for diabetic kidney disease. [PDF]

open access: yesRen Fail
Xu Y   +8 more
europepmc   +1 more source

Hemoglobin resident in the lung epithelium is protective for smooth muscle soluble guanylate cyclase function. [PDF]

open access: yesRedox Biol, 2023
Sumi MP   +7 more
europepmc   +1 more source

The Novel Soluble Guanylate Cyclase Stimulator Attenuates Acute Lung Injury via Inhibiting Pericyte Phenotypic Transition. [PDF]

open access: yesInt J Mol Sci
Huang YL   +12 more
europepmc   +1 more source

Treatment effects of soluble guanylate cyclase modulation on diabetic kidney disease at single-cell resolution. [PDF]

open access: yesCell Rep Med, 2023
Balzer MS   +11 more
europepmc   +1 more source

Bioelectrochemical monitoring of soluble guanylate cyclase inhibition by the natural beta-carboline canthin-6-one

open access: yes, 2017
The inhibition of soluble guanylate cyclase (sGC) by canthin-6-one alkaloid (L1) is presented and the mechanism of deactivation is studied using solution phase and voltammetry of microparticles methodologies.
Cebrian-Torrejon, G.   +6 more
core  

Soluble Guanylate Cyclase Stimulators in Heart Failure. [PDF]

open access: yesCureus, 2021
Kansakar S   +7 more
europepmc   +1 more source

Stimulation of soluble guanylate cyclase by vericiguat reduces skeletal muscle atrophy of mice following chemotherapy. [PDF]

open access: yesFront Pharmacol, 2023
Hu BA   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy